EpiPen competitor Auvi-Q to return to market

An alternative epinephrine injector to the EpiPen is returning to the market and this one talks.

The Auvi-Q was recalled in 2015 for what the Federal Drug Administration called a potentially inaccurate dosage delivery but has announced its return Feb. 14.

Dr. Philip Gallagher said this injector has its benefits because of its step by step instruction.
   
"So if you had a babysitter and you show them and there's a problem it will talk them through it,” Gallagher said.

This relaunch of the Auvi-Q comes months after outrage grew over the Mylan Co. hiking EpiPen prices to $600 for a two-pack.

Reports say Auvi-Q will be available free of charge for some patients with private insurance.


More Stories

Don't Miss

  • 2018 YourErie.com Golf Pass
    Copyright 2017 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
  • Bianchi Honda SkyCam Network
    Copyright 2017 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
  • Contests

Trending Stories

Latest News

Video Center